Skip to content

Osteopathic treatments for patients with episodic migraine

Osteopathic treatments for patients with episodic migraine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00026794
Enrollment
330
Registered
2021-10-13
Start date
2021-10-15
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43.1

Interventions

Group 1: 5 osteopathic treatments within 12 weeks Group 2: untreated (waiting list) for 12 weeks, then 5 osteopathic treatments

Sponsors

Akademie für Osteopathie e.V.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Patients must have a diagnosis of migraine, with or without aura, according to International Headache Society criteria - 4 to <15 migraine days/ per month during the 3 months prior to study entry - Migraine must have been present for at least 12 months - A written informed consent form must be signed - Sufficient knowledge of the German language

Exclusion criteria

Exclusion criteria: - Onset of headache after the age of 50. - Use of analgesics more than 3 days per month for other chronic pain. - Pregnancy; lactation - Patients with pre-existing heart disease - Patients with relatively severe systemic diseases - Patients with neurological diseases - Osteopathic treatments during the last 12 months - Chronic migraine - tension-type headache more than 10 days per month - menstrual migraine with or without aura - Trigeminal autonomic headache disorders - Secondary headache disorders

Design outcomes

Primary

MeasureTime frame
Do osteopathic treatments of patients with episodic migraine have an influence on the number of migraine days/month recorded with the electronic headache diary of the Kiel Pain Clinic

Secondary

MeasureTime frame
Recording the severity of the migraine attack, functional impairment, assessment of quality of life, medication use during the attack, and side effects of therapy.

Countries

Germany

Contacts

Public ContactFlorian Schwerla

Akademie für Osteopathie e.V.

info@osteopathie-akademie.de+49 89 49340068

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026